reflect improv growth profil franchis
page full analyst note aug
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research aug
estim aug
price data aug
rate updat aug
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
stori one constant chang firm
found manufactur compon world war ii aircraft
final divest industri busi full
transit medic devic thereaft leadership
former ceo benson smith compani complet transit
industri conglomer pure-play medic devic
manufactur core busi focus vascular surgeri
anesthesia end market
firm effect carv nich market
compet thu far remain rel insul
intens competit
med-tech
manag target market opportun
compani suppli dispos product
mandatori
procedur creat rel stabl demand associ
cash flow addit product portfolio primarili contain
low-dollar-valu item along increment innov
allow compani improv margin profil modest
price inflat time combin like-for-lik price
power smith character direct market access core tenet
compani strategi led slowli acquir
foreign distribut partner provid better line sight
end market allow firm captur otherwis lost
distributor margin lead sustain predict gross
smith retir end anticip strategi
like remain unchang new ceo former
liam kelli recent acquisit vascular solut
neotract help improv firm margin profil believ
high price paid limit contribut return invest
capit near term addit grow goodwil
compon firm invest capit base held histor
return weight averag cost capit wed like
see evid compani trend toward sustain
econom profit gener award moat
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
wayn pennsylvania-bas manufactur hospit suppli
medic devic primarili vascular access surgic area
firm report eight primari segment vascular north america
sale intervent north america anesthesia north
asia original-equip manufactur
geograph exposur busi primarili
account revenu intern market make
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
reflect improv growth profil
put impress result second
quarter constant-curr revenu growth
year year nearli adjust ship
day varianc affect compar good portion
out-performance stem strength urolift
product post growth compar
estim result underli acceler across
constant-curr growth target roughli basi point
off-set somewhat stronger currenc headwind
throughout second half rais fair
valu estim no-moat firm per share
reflect posit model howev
market imput valuat multipl time
earn project find hard justifi buy
share current price last time share reach
valuat level end trade sideway
follow month
manag
notabl updat revenu outlook impli growth
remaind year near high end firm
long-term expect nearli
figur anticip come outsiz growth
urolift roughli attribut firm underli
busi figur probabl impli acceler
underli growth rate rel perform seen
last sever quarter
despit solid revenu result manag maintain
earn per share target lower adjust
oper margin outlook roughli basi point
currenc on-going salesforc invest account
step-down anticip sustain margin
expans roughli basi point annual
longer term firm mani restructur initi work
cost structur manag on-going focu
drive growth firm higher-margin product
highlight last quarter manag frank
firm capac pursu anoth transform
transact like par billion all-in price
tag neotract sound team expect
anyth particularli soon especi valuat
trend toward frothi level howev
balanc sheet sit time net leverag firm
sizabl amount dri power interest
rais fair valu estim per share
account recent perform better
growth prospect embed model valuat
impli roughli time time estim
adjust earn ebitda respect
updat outlook project busi continu
solid perform anticip firm increas
revenu near compound annual growth rate
forecast period outlook newli acquir
vascular solut neotract busi drive
expect acceler growth add nearli
respect growth core
improv gross margin mix addit
busi inform expect nearli basi
point gross margin gain baselin
forecast consist manag goal
adjust oper margin trend toward time
mix play critic role good portion
project margin expans firm profit
core also pois improv on-going
given uncertainti creat integr sizabl
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
forecast fall well short manag target
result valuat per share nearer time
time time lower estim adjust
earn ebitda sale respect
yet clear us abl dig
moat firm develop lead posit hand
market acquisit dont yet
confid meaning outperform
estim wacc decad believ
conting
manag abil sourc valu integr futur
acquisit constitut basi
moat histor profil support
stanc -- prior acquisit yet materi
enhanc firm return given substanti goodwil
alloc recur cost relat integr
restructur effort suggest deal valuat
expens side wed like see
evid valu creation adjust current view
howev think manag strategi target
product low absolut price point effect
hospit continu becom
sensit firm product portfolio somewhat uniqu
item carri sticker price less
believ help insul busi
industrywid price pressur thu far actual
allow compani rais price modestli time
howev believ manag act
price opportun avail compani assum
price benefit go forward mix relat rather
like-for-lik price power view firm vascular
surgic anesthesia franchis area like
develop futur moat firm respiratori
oem busi rather commodit
overal focus acquir product
acquisit complet cours last year
rate uncertainti high bull case
incorpor busi fundament valuat
believ would like associ takeout-lik
level forecast core revenu acceler
period enhanc growth profil
vascular solut neotract result compound-annual-growth-rate
forecast period addit assum
manag oper margin target
exceed result valu per share
approxim time time time bull-cas
forecast adjust earn ebitda sale
bear case contempl scenario sizabl
impair goodwil would like occur case
forecast slow core revenu growth less-than-stellar
contribut recent acquisit result
revenu compound-annual-growth-rate approxim addit
estim restructur effort fail meaning
expand core gross margin oper expens
level fail meet exist synergi target
still expect oper margin expand case
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
compet rel oligopolist market structur
top three four competitor make gener two
third total market vascular access
cathet laryng mask laparoscop surgeri
gener compet hand firm
mani case lead product arrow
line central cathet lma laryng mask portfolio
competit posit current favor
clear firm develop sourc
advantag give us confid abil defend
better capit competitor
medic suppli industri gener view
switch cost intang asset cost advantag
like sourc underpin competit moat
focus enhanc product portfolio
acquisit isnt support moat
isol view dont see evid
moat sourc present product portfolio
center around low-cost single-us product reli
physician prefer group purchas organ
gpo contract repeat sale deepli
either procur
administr end user addit firm margin
profil on-going manufactur consolid
restructur effort suggest us uniqu cost
advantag current exist -- although anticip
margin improv come year manag
optim compani cost structur
hesit award moat base
intang sourc alon given firm underinvest
research develop compar peer
sinc transit pure-play medic busi
compani spent revenu averag
research develop effort versu peer becton
dickinson bard spent
nearer high singl digit percentag revenu basi
multipl abl spend
absolut dollar us impli compon
strategi outsiz impact rel
competitor believ put firm
environ attract
acquisit hard come
appear manag appetit acquisit
acceler cours close two deal
billion total valu think
deal includ interest asset dont believ
combin inher enhanc valu
combin compani competit posit expect
addit vascular solut neotract
improv firm growth margin profil
concern valuat paid limit accret
near term dont anticip impli return
sharehold deal exceed estim
firm cost capit three four year
doesnt jump us obvious value-add proposit
addit neotract repres one riski
opportun taken given billion
all-in price single-product firm year
view underli moat trend stabl
compani enjoy modest share gain year
undergon acquisit enhanc
firm posit tangenti market believ
product ad uniqu opportun
product portfolio dont view inclus
asset sustain improv weaken
underli competit posit
busi
addit valuat paid look expens
side rather obviou bargain calcul
manag commentari
accret combin near term us
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
limit return improv suggest underli
moat sourc unlik improv inclus
acquisit alon
believ potenti upsid exist base-cas
assumpt regard acquisit particularli
case neotract given larg unmet need within
benign prostat hyperplasia market want remain
cogniz bigger pictur believ
need continu sourc acquisit backfil
research develop pipelin increas
uncertainti regard develop platform abil
busi respond effect competit
pressur view addit either
recent deal fail meet expect believ
materi risk capit base given current make-up
compani balanc sheet case
intang asset goodwil make nearli total
asset valu versu peer closer averag
pursu similar strategi monitor
progress deal chang firm-wide
care evid posit neg inflect
assess compani underli moat trend
final concern focus
product market limit barrier entri
product littl way intang
regul framework minim switch
cost outsid inertia part hospit procur
administr favor gpo relationship combin
underinvest intern worri
defens firm current market posit
given size scope primari competitor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
gross margin profil meaning
improv higher-margin vascular solut
neotract begin outgrow core franchis
clinic benefit area unmet need market
opportun substanti could repres home-
run acquisit sale continu grow
owhil firm financi model continu
perform ahead expect perform
recent acquisit critic meet free
ohistor acquisit yet materi
compani profil given
substanti goodwil alloc verdict still
manag capital-alloc prowess
product portfolio competit strategi
resembl bard could make
viabl takeout candid given bard acquisit
goodwil intang asset much
larger portion balanc sheet compar
peer pursu similar strategi could indic
overpay histor deal
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
think financi posit solid follow
substanti balanc sheet de-lever wake
acquisit firm complet debt
fell near time adjust ebitda moder ahead
histor rang well support firm growth
prospect believ compani strong cash flow
profil along continu growth oper
leverag put leverag time
end result surpris
see announc transact end
year estim firm approxim million
tax-affect pension oblig nearli million
off-balance-sheet leas financ modestli worsen
littl less billion gross debt estim
time howev believ compani adequ
access liquid form million annual
free cash flow along million current avail
revolv line credit
risk associ
assign high uncertainti rate due
acquisit despit otherwis stabl cash flow profil
near term would highlight potenti
value-destruct post-leadership transit
rel unconcern possibl given kelli
tenur addit expect integr
vascular solut neotract produc
wacc return capit within year high price
paid creat meaning risk capit base expect
growth fail materi highlight risk stem
firm limit invest realiz return
intern activ view compani intern
develop engin somewhat lack would
highlight materi underinvest versu peer
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
spent roughli sale averag
last five year versu bard north becton
dickinson near better
averag fill gap acquisit
anticip continu find value-add
candid critic firm success believ
signific portion compani product portfolio
limit protect custom switch cost
enhanc risk firm current market
posit view market environ provid
acquisit candid new manag team
fail effect sourc opportun think risk
put structur competit disadvantag
time
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
new york mellon corp
share
fund
share
fund
success firm leadership benson
smith smith serv board
member sinc elev ceo role mark
end histori industri conglomer
signal board support firm evolut
signific medic devic experi teleflex
c-suit spent nearli year career
bard includ late believ
manag effect alloc sharehold capit
year acquisit divestitur activ
build medic portfolio also like
nich product strategi compani pursu
larg insul busi price pressur
seen broadli across industri last year
smith retir end preclud us
award team exemplari rate although new ceo
liam kelli part compani execut team
sinc sinc wed like get
better sens strateg vision capital-alloc
overal view manag compens reason
believ interest manag team
align minor sharehold insid
ownership encourag corpor director
offic own outstand share includ
underli option restrict stock unit
smith own compani addit
annual compens structur includ roughli
equiti base pay meaning vest period
view posit annual option grant vest ratabl
three-year period annual rsu vest
entireti three-year period perform metric
base primarili annual revenu earn per share
target combin weight tie oper
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
cash flow remain individu target
think consist mani compani cover
wed prefer heavier emphasi cash flow return
capit opinion better measur
corpor perform adjust incom statement
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
reflect improv growth profil
put impress result second
quarter constant-curr revenu growth
year year nearli adjust ship
day varianc affect compar good portion
out-performance stem strength urolift
product post growth compar
estim result underli acceler across
constant-curr growth target roughli basi point
off-set somewhat stronger currenc headwind
throughout second half rais fair
valu estim no-moat firm per share
reflect posit model howev
market imput valuat multipl time
earn project find hard justifi buy
share current price last time share reach
valuat level end trade sideway
follow month
manag
notabl updat revenu outlook impli growth
remaind year near high end firm
long-term expect nearli
figur anticip come outsiz growth
urolift roughli attribut firm underli
busi figur probabl impli acceler
underli growth rate rel perform seen
last sever quarter
despit solid revenu result manag maintain
earn per share target lower adjust
oper margin outlook roughli basi point
currenc on-going salesforc invest account
step-down anticip sustain margin
expans roughli basi point annual
longer term firm mani restructur initi work
cost structur manag on-going focu
drive growth firm higher-margin product
highlight last quarter manag frank
firm capac pursu anoth transform
transact like par billion all-in price
tag neotract sound team expect
anyth particularli soon especi valuat
trend toward frothi level howev
balanc sheet sit time net leverag firm
sizabl amount dri power interest
first-quart result put teleflex track
first-quart result consist
expect underli basi report number
fell slightli short due stronger currenc headwind
anticip nevertheless appear firm well
way meet forecast full year
like rais per share fair valu estim
no-moat name mid-single-digit percentag account
cash flow receiv sinc last updat
firm post constant currenc revenu growth
ahead initi guidanc call full
year strength broad base across geographi
product segment new product firm
intervent portfolio continu outpac core
busi neotract particular continu impress
revenu growth quarter pace beat
estim full year restructur charg
also came ahead model due quick ramp-up
cost associ manag footprint
year good start surpris
see return sizabl dealmak later
year net leverag declin roughli time
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
product global invest limit firm abil
drive oper leverag come year
contend underli perform continu trend
line manag long-term outlook
final firm announc anoth restructur plan
help support gross margin outlook
enterpris time compani adept
improv cost good year even
control benefit attribut acquir higher-
margin line busi last year
firm leverag ratio set fall time
surpris see manag pursu
anoth larger transact medium term
adjust ebitda anticip metric fall
nearer time end balanc sheet
look much improv follow success neotract
vascular solut integr leav manag
billion dri powder avail without
go much high end histor
time net leverag coven surpris
see debt level rise level sustain period
full-year result initi outlook
no-moat report result fell line
expect provid initi outlook
larg bracket estim like rais
per share fair valu estim mid-single-digit
percentag account cash flow receiv sinc
last updat dont intend make mani meaning
chang assumpt
notabl firm report full-year organ constant-
currenc revenu growth near low end
manag forecast previous
anticip includ out-performance
neotract vascular solut versu fourth-quart
remain mute explain modest neg market
reaction news forward guidanc look reason
good manag anticip constant-
currenc revenu growth although compani face
headwind currenc cours
year versu benefit seen earn
fell line project includ modest
increment spend associ get firm
urolift product reimburs japan follow earlier-
than-expect approv expand sale support
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
